Imperial College London


Faculty of MedicineInstitute of Global Health Innovation

Visiting Professor



+44 (0)7554 342 293robert.istepanian Website




Central FacultyFaculty BuildingSouth Kensington Campus






BibTex format

author = {Istepanian, RSH and Casiglia, D and Gregory, JW},
doi = {10.12968/bjhc.2017.23.3.102},
journal = {British Journal of Health Care Management},
pages = {102--108},
title = {Mobile health (m-Health) for Diabetes management},
url = {},
volume = {23},
year = {2017}

RIS format (EndNote, RefMan)

AB - © MA Healthcare Ltd. Diabetes is a major health challenge with a global impact regardless of age, country or economic condition. The increased prevalence of diabetes is reaching alarming levels. The necessity and urgency to find innovative care delivery solutions is becoming more important, particularly in the digital age. It is expected in the near future that more people with diabetes, especially the younger generations will be empowered by their smartphones and relevant mobile health (m-Health) innovations, to take more responsibility of their condition. Clinicians and healthcare providers are increasingly likely to assume the role of 'navigators' and 'advisors' rather than simply the medical gatekeeper for their patients. In this article, we describe the general architecture of current m-Health systems and applications for diabetes management. We also discuss the clinical evidence for impact from these important and innovative approaches to diabetes self-care and management and likely future trends in their usage. The latest statistics indicate that there are more than 1200 diabetes smartphone 'apps' and this area is growing exponentially in terms of ideas, technologies, devices and the associated industry. M-Health for diabetes care is now a major business stream for the medical device, mobile phone and IT telecommunication industries with high expectations arising from the potential benefits to be gained by both patients and healthcare providers. However, this potential has not yet been fully developed on the clinical side. This may be due to many factors including the reluctance of clinicians to engage with these technologies due to the lack of clinical evidence for their efficacy, poor adherence of people with diabetes to longterm use of these apps and the reluctance of healthcare funders to reimburse mobile diabetes.
AU - Istepanian,RSH
AU - Casiglia,D
AU - Gregory,JW
DO - 10.12968/bjhc.2017.23.3.102
EP - 108
PY - 2017///
SN - 1358-0574
SP - 102
TI - Mobile health (m-Health) for Diabetes management
T2 - British Journal of Health Care Management
UR -
VL - 23
ER -